10
Total investments
7
Early stage
0
Mid stage
1
Late stage
4y
Years active
Portfolio
9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Aug 2025
Companies waste billions on bad ads, mismatched landing pages, and poor budget allocation. Uplane fixes this by replacing a patchwork of agencies, spreadsheets, and siloed tools with one self-improving system. It creates ads, builds matching landing pages, allocates budgets across different channels and more, all in real time.
Angel Investor
Jul 2025
5U AI surrounds every logistics company with digital workers that listen, learn, and act in the background, turning unstructured noise into instant, confident actions.
Angel Investor
May 2025
Lyceum is a GPU cloud platform built for AI teams in Europe.
We offer inference APIs, serverless execution, GPU VMs, and managed clusters. Designed to work individually or together. Whether youre training and fine-tuning LLMs, running large-scale batch inference, powering real-time AI applications, or processing compute-heavy scientific workloads. Lyceum handles the infrastructure so you can focus on building.
Angel Investor
Mar 2025
Condukt is the next-generation know-your-business platform for financial services, offering an agentic solution powered by real-time data. Always-on and policy-aware, Condukt enables financial institutions and fintechs to gain actionable insights into business verification - unlocking growth, increasing efficiency, and strengthening compliance. Trusted by leading regulated entities, including Wise, Tide, Mollie, Rakuten, Flatpay, and myPOS, London-headquartered Condukt is backed by Lightspeed Venture Partners and MMC Ventures.
Learn more at condukt.co
Angel Investor
Feb 2025
Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity. Built on deeptech innovation, the company combines proprietary 3D- bioprinting technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring organ function and replacing damaged tissue with living, functional implants – produced reliably and at scale.
For inquiries please contact:
Moritz Marschall
mm@cellbricks.com
Angel Investor
Oct 2024
The future of product development in the era of frontier AI. We’re helping product and growth teams simulate user behavior before shipping code. With Blok you can test ideas in hours, not weeks, and uncover issues before they become expensive mistakes. Build with us: https://joinblok.notion.site/Open-Roles-at-Blok-21c5df33b374800da3d2de6fb065eb96
Angel Investor
Nov 2023
AI-powered testing tool for web apps that finds bugs before your users do. We only need your website’s URL. Our AI agent knows what to test, writes the tests and keeps them relevant. Run the tests from our app or plug them into your CI/CD pipeline. Beta out now 🟢
Angel Investor
Sep 2023
Huzzle connects world-class experts with AI labs and enterprises.
We use our AI recruiter to source, multi-stage vet, and train large volumes of talent while maintaining consistently high quality.
Experience · 15 entries
All (15)
Investments (10)
Founder (3)
2025
Angel Investor
Aug 2025
Companies waste billions on bad ads, mismatched landing pages, and poor budget allocation. Uplane fixes this by replacing a patchwork of agencies, spreadsheets, and siloed tools with one self-improving system. It creates ads, builds matching landing pages, allocates budgets across different channels and more, all in real time.
Angel Investor
Jul 2025
5U AI surrounds every logistics company with digital workers that listen, learn, and act in the background, turning unstructured noise into instant, confident actions.
Angel Investor
May 2025
Lyceum is a GPU cloud platform built for AI teams in Europe.
We offer inference APIs, serverless execution, GPU VMs, and managed clusters. Designed to work individually or together. Whether youre training and fine-tuning LLMs, running large-scale batch inference, powering real-time AI applications, or processing compute-heavy scientific workloads. Lyceum handles the infrastructure so you can focus on building.
Angel Investor
Mar 2025
Condukt is the next-generation know-your-business platform for financial services, offering an agentic solution powered by real-time data. Always-on and policy-aware, Condukt enables financial institutions and fintechs to gain actionable insights into business verification - unlocking growth, increasing efficiency, and strengthening compliance. Trusted by leading regulated entities, including Wise, Tide, Mollie, Rakuten, Flatpay, and myPOS, London-headquartered Condukt is backed by Lightspeed Venture Partners and MMC Ventures.
Learn more at condukt.co
Angel Investor
Feb 2025
Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity. Built on deeptech innovation, the company combines proprietary 3D- bioprinting technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring organ function and replacing damaged tissue with living, functional implants – produced reliably and at scale.
For inquiries please contact:
Moritz Marschall
mm@cellbricks.com
Show all 15 entries ↓
Investment activity
2022–2025 · 10 investments
Recent (last 2 years)Earlier
